These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33972248)

  • 1. Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial.
    Wasserman S; Davis A; Stek C; Chirehwa M; Botha S; Daroowala R; Bremer M; Maxebengula M; Koekemoer S; Goliath R; Jackson A; Crede T; Naude J; Szymanski P; Vallie Y; Moosa MS; Wiesner L; Black J; Meintjes G; Maartens G; Wilkinson RJ
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0014021. PubMed ID: 33972248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial.
    Cresswell FV; Meya DB; Kagimu E; Grint D; Te Brake L; Kasibante J; Martyn E; Rutakingirwa M; Quinn CM; Okirwoth M; Tugume L; Ssembambulidde K; Musubire AK; Bangdiwala AS; Buzibye A; Muzoora C; Svensson EM; Aarnoutse R; Boulware DR; Elliott AM
    Clin Infect Dis; 2021 Sep; 73(5):876-884. PubMed ID: 33693537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
    Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
    Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients.
    Yunivita V; Dian S; Ganiem AR; Hayati E; Hanggono Achmad T; Purnama Dewi A; Teulen M; Meijerhof-Jager P; van Crevel R; Aarnoutse R; Ruslami R
    Int J Antimicrob Agents; 2016 Oct; 48(4):415-21. PubMed ID: 27526979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-Based Meta-analysis of Rifampicin Exposure and Mortality in Indonesian Tuberculous Meningitis Trials.
    Svensson EM; Dian S; Te Brake L; Ganiem AR; Yunivita V; van Laarhoven A; Van Crevel R; Ruslami R; Aarnoutse RE
    Clin Infect Dis; 2020 Nov; 71(8):1817-1823. PubMed ID: 31665299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis.
    Te Brake L; Dian S; Ganiem AR; Ruesen C; Burger D; Donders R; Ruslami R; van Crevel R; Aarnoutse R
    Int J Antimicrob Agents; 2015 May; 45(5):496-503. PubMed ID: 25703312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis.
    Mezochow A; Thakur KT; Zentner I; Subbian S; Kagan L; Vinnard C
    Int J Infect Dis; 2019 Jul; 84():15-21. PubMed ID: 31051278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
    Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
    Trials; 2011 Feb; 12():25. PubMed ID: 21288325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis.
    Pouplin T; Bang ND; Toi PV; Phuong PN; Dung NH; Duong TN; Caws M; Thwaites GE; Tarning J; Day JN
    BMC Infect Dis; 2016 Apr; 16():144. PubMed ID: 27039088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis.
    Ruslami R; Gafar F; Yunivita V; Parwati I; Ganiem AR; Aarnoutse RE; Wilffert B; Alffenaar JC; Nataprawira HM
    Arch Dis Child; 2022 Jan; 107(1):70-77. PubMed ID: 34183327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose rifampicin for the treatment of tuberculous meningitis: a meta-analysis of randomized controlled trials.
    Cao Y; Wang T; He K; Xue J; Wang X; Liang J
    J Clin Pharm Ther; 2022 Apr; 47(4):445-454. PubMed ID: 34897758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study).
    Cresswell FV; Ssebambulidde K; Grint D; Te Brake L; Musabire A; Atherton RR; Tugume L; Muzoora C; Lukande R; Lamorde M; Aarnoutse R; Meya D; Boulware DR; Elliott AM
    Wellcome Open Res; 2018; 3():83. PubMed ID: 30175245
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis.
    Dian S; Yunivita V; Ganiem AR; Pramaesya T; Chaidir L; Wahyudi K; Achmad TH; Colbers A; Te Brake L; van Crevel R; Ruslami R; Aarnoutse R
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.
    Abulfathi AA; Decloedt EH; Svensson EM; Diacon AH; Donald P; Reuter H
    Clin Pharmacokinet; 2019 Sep; 58(9):1103-1129. PubMed ID: 31049868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.
    Davis AG; Wasserman S; Stek C; Maxebengula M; Jason Liang C; Stegmann S; Koekemoer S; Jackson A; Kadernani Y; Bremer M; Daroowala R; Aziz S; Goliath R; Lai Sai L; Sihoyiya T; Denti P; Lai RPJ; Crede T; Naude J; Szymanski P; Vallie Y; Banderker IA; Moosa MS; Raubenheimer P; Candy S; Offiah C; Wahl G; Vorster I; Maartens G; Black J; Meintjes G; Wilkinson RJ
    Clin Infect Dis; 2023 Apr; 76(8):1412-1422. PubMed ID: 36482216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment.
    Stemkens R; Litjens CHC; Dian S; Ganiem AR; Yunivita V; van Crevel R; Te Brake LHM; Ruslami R; Aarnoutse RE
    Int J Antimicrob Agents; 2019 Sep; 54(3):371-374. PubMed ID: 31202922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid Population Pharmacokinetic Model in Plasma and Cerebrospinal Fluid Among Patients With Tuberculosis Meningitis.
    Abdelgawad N; Wasserman S; Abdelwahab MT; Davis A; Stek C; Wiesner L; Black J; Meintjes G; Wilkinson RJ; Denti P
    J Infect Dis; 2024 Apr; 229(4):1200-1208. PubMed ID: 37740554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of high-dose rifampicin in the management of tuberculosis meningitis: Systematic review and meta-analysis.
    Charlie L; Abay SM; Tesfaye A; Mlera RN; Mwango S; Goretti M
    Int J Mycobacteriol; 2021; 10(3):312-319. PubMed ID: 34494572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
    Heemskerk AD; Nguyen MTH; Dang HTM; Vinh Nguyen CV; Nguyen LH; Do TDA; Nguyen TTT; Wolbers M; Day J; Le TTP; Nguyen BD; Caws M; Thwaites GE
    Clin Infect Dis; 2017 Jul; 65(1):20-28. PubMed ID: 28472255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.